SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,986.51 -463.99
(-1.00%)

Dow Jones

6,496.71 -116.19
(-1.76%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,975.43 -131.41
(-1.30%)

Forex

USD-INR

93.86 0.07
(0.08%)

EUR-INR

108.76 0.06
(0.06%)

GBP-INR

125.66 0.01
(0.01%)

JPY-INR

0.59 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

98.67

430644.64

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.89

Back

Aqylon Nexus reports standalone net profit of Rs 1.48 crore in the December 2025 quarter

Feb 11,2026

Net profit of Aqylon Nexus reported to Rs 1.48 crore in the quarter ended December 2025 as against net loss of Rs 22.73 crore during the previous quarter ended December 2024. Sales rose 109.75% to Rs 4.95 crore in the quarter ended December 2025 as against Rs 2.36 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4.95	2.36	110
OPM %	36.97	4.24	-
PBDT	1.49	0.15	893
PBT	1.48	0.11	1245
NP	1.48	-22.73	LP

73,583.22 -1,690.23 ( -2.25%)

45,986.51 -463.99 (-1.00%)

6,496.71 -116.19 (-1.76%)

53,412.46 -191.19 (-0.36%)

9,975.43 -131.41 (-1.30%)

93.86 0.07 (0.08%)

108.76 0.06 (0.06%)

125.66 0.01 (0.01%)

0.59 0.00 (-0.13%)